Brick
TSE:BRKThe Brick Ltd. (The Brick) is a retailer of household furniture, mattresses, appliances and home electronics, operating under four banners: The Brick, United Furniture Warehouse, The Brick Mattress Store, and Urban Brick. The Company has two operating segments: Retail and Financial Services. The Company operates retail stores concentrating on the sales of furniture, mattresses, appliances and electronics. Retail customers are offered credit though the Brick Card which is funded and billed by unrelated external service providers. The Financial Services segment is primarily engaged in providing extended warranty services on products sold to customers of The Brick and credit insurance on balances that arise from customers' use of their Brick Card. As at December 31, 2011, The Brick operated 232 retail store, including 60 franchise locations. The Brick owns 100% of the limited partnership units of The Brick Warehouse LP. In March 2013, Leon's Furniture Ltd acquired Brick Ltd.
Protalix BioTherapeutics
NYSE:PLXProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Ultra Petroleum
NASDAQ:UPLUltra Petroleum Corp., an independent oil and gas company, engages in the acquisition, exploration, development, operation, and production of oil and natural gas properties. Its principal business activities are developing its natural gas reserves in the Green River Basin of southwest Wyomingthe Pinedale and Jonah fields. As of December 31, 2018, the company owned interests in approximately 114,000 gross acres in Wyoming. The company was founded in 1979 and is headquartered in Englewood, Colorado.
Petro-Victory Energy
CVE:VRYPetro-Victory Energy Corp., through its subsidiaries, engages in the acquisition and development of crude oil and natural gas resources in Latin America. The company was incorporated in 2014 and is based in Dallas, Texas.